Inventor · disambiguated record
Rolf Guenther
Also filed as: GUENTHER ROLF · GUENTHER ROLF W
4 granted patents·5 pending applications·1,019 citations·filing 1990–2022
75Inventor score
Files withPOEHLMANN TOBIAS2UNIV JENA FRIEDRICH SCHILLER2UNIV SCHILLER JENA2COOK INC1GUENTHER ROLF W1
Top patents by PatentIndex Score
9 records- 0190US5102415AApparatus for removing blood clots from arteries and veinsGUENTHER ROLF W·Filed 1990·Granted Apr 7, 1992·1k cites·8 claims
- 0269US7943161B2Contrast agent coated medical deviceCOOK INC·Filed 2005·Granted May 17, 2011·4 cites·20 claims
- 0361US12472262B2Peptide for use in the reduction of side effects in the form of immunostimulatory reactions/effectsUNIV JENA FRIEDRICH SCHILLER·Filed 2022·Granted Nov 18, 2025·0 cites·9 claims
- 0445US2020230251A1Peptide for use in the reduction of side effects in the form of immunostimulatory reactions/effectsUNIV JENA FRIEDRICH SCHILLER·Filed 2015·Application pending·0 cites
- 0542US2004067502A1Multiplex assays using nanoparticlesFiled 2001·Application pending·0 cites
- 0640US2016193362A1New cell-specifically active nucleotide molecules and application kit for the application thereofUNIV SCHILLER JENA·Filed 2013·Application pending·0 cites
- 0737US2017233760A1Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kitPOEHLMANN TOBIAS·Filed 2012·Application pending·0 cites
- 0836US9353369B2Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereofPOEHLMANN TOBIAS·Filed 2011·Granted May 31, 2016·0 cites·9 claims
- 0936US2016145623A1METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USEUNIV SCHILLER JENA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rolf Guenther files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →